Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Andreas Menke. (2018) Precision pharmacotherapy: psychiatry’s future direction in preventing, diagnosing, and treating mental disorders. Pharmacogenomics and Personalized Medicine 11, pages 211-222.
Read now
Read now
Margret R. Hoehe & Deborah J. Morris-Rosendahl. (2018) The role of genetics and genomics in clinical psychiatry. Dialogues in Clinical Neuroscience 20:3, pages 169-177.
Read now
Read now
Seetal Dodd, Philip B. Mitchell, Michael Bauer, Lakshmi Yatham, Allan H. Young, Sidney H. Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Roger S. McIntyre, Michael E. Thase, Raymond W. Lam, Emanuel Severus, Siegfried Kasper & Michael Berk. (2018) Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry 19:5, pages 330-348.
Read now
Read now
Chiara Fabbri, Concetta Crisafulli, Marco Calabrò, Edoardo Spina & Alessandro Serretti. (2016) Progress and prospects in pharmacogenetics of antidepressant drugs. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1157-1168.
Read now
Read now
Amtul H. Changasi, Tahireh A. Shams, Jennie G. Pouget & Daniel J. Müller. (2014) Genetics of antipsychotic drug outcome and implications for the clinician: into the limelight. Translational Developmental Psychiatry 2:1.
Read now
Read now
Articles from other publishers (52)
Susanne B. Haga. (2023) The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S. Pharmacy 11:5, pages 144.
Crossref
Crossref
Shahariar Mohammed Fahim, Courtney S. Watts Alexander, Jingjing Qian, Surachat Ngorsuraches, Natalie S. Hohmann, Kimberly Braxton Lloyd, Adrianna Reagan, Lauren Hart, Nicholas McCormick & Salisa C. Westrick. (2023) Current published evidence on barriers and proposed strategies for genetic testing implementation in health care settings: A scoping review. Journal of the American Pharmacists Association 63:4, pages 998-1016.
Crossref
Crossref
Danilo Arnone, Omar Omar, Teresa Arora, Linda Östlundh, Reshma Ramaraj, Syed Javaid, Romona Devi Govender, Bassam R. Ali, George P. Patrinos, Allan H. Young & Emmanuel Stip. (2023) Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neuroscience & Biobehavioral Reviews 144, pages 104965.
Crossref
Crossref
Maria L. Ricardo-Silgado, Sneha Singh, Lizeth Cifuentes, Paul A. Decker, Daniel Gonzalez-Izundegui, Ann M. Moyer, Maria D. Hurtado, Michael Camilleri, Suzette J. Bielinski & Andres Acosta. (2022) Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC Medicine 20:1.
Crossref
Crossref
Korlan Z. Saduakassova & Gulnara S. Svyatova. (2022) Population features of alleles and genotypes frequency distribution of polymorphic genetic markers of antipsychotic medications pharmacokinetics in the Kazakh population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 189:3-4, pages 100-107.
Crossref
Crossref
Gabriel Eckermann. 2022. Elsevier Essentials Migration & Gesundheit. Elsevier Essentials Migration & Gesundheit
155
158
.
Samar S. M. Elsheikh, Daniel J. Müller & Jennie G. Pouget. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
389
425
.
Kazunari Yoshida, Emiko Koyama, Clement C. Zai, Joseph H. BeitchmanJames L. Kennedy, Yona Lunsky, Pushpal Desarkar & Daniel J. Müller. (2020) Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. The Canadian Journal of Psychiatry 66:12, pages 1019-1041.
Crossref
Crossref
Antonio F. Pardiñas, Michael J. Owen & James T.R. Walters. (2021) Pharmacogenomics: A road ahead for precision medicine in psychiatry. Neuron 109:24, pages 3914-3929.
Crossref
Crossref
Isabelle Austin-Zimmerman, Marta Wronska, Baihan Wang, Haritz Irizar, Johan H. Thygesen, Anjali Bhat, Spiros Denaxas, Ghazaleh Fatemifar, Chris Finan, Jasmine Harju-Seppänen, Olga Giannakopoulou, Karoline Kuchenbaecker, Eirini Zartaloudi, Andrew McQuillin & Elvira Bramon. (2021) The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes 12:11, pages 1758.
Crossref
Crossref
Francisco José Toja-Camba, Nerea Gesto-Antelo, Olalla Maroñas, Eduardo Echarri Arrieta, Irene Zarra-Ferro, Miguel González-Barcia, Enrique Bandín-Vilar, Victor Mangas Sanjuan, Fernando Facal, Manuel Arrojo Romero, Angel Carracedo, Cristina Mondelo-García & Anxo Fernández-Ferreiro. (2021) Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics. Pharmaceutics 13:7, pages 935.
Crossref
Crossref
Nikolay N. Ivanets, Andrey A. Svistunov, Vladimir N. Chubarev, Marina A. Kinkulkina, Yuliya G. Tikhonova, Nikita S. Syzrantsev, Susanna S. Sologova, Nelly V. Ignatyeva, Kerim Mutig & Vadim V. Tarasov. (2021) Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?. Current Pharmaceutical Design 27:2, pages 305-318.
Crossref
Crossref
Chad A. Bousman, Susanne A. Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, Harald Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert M. Stowe, Ene-Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk & Daniel J Müller. (2020) Review and Consensus on Pharmacogenomic Testing in
Psychiatry. Pharmacopsychiatry 54:01, pages 5-17.
Crossref
Crossref
Abdullah Al Maruf, Mikayla Fan, Paul D. Arnold, Daniel J. Müller, Katherine J. Aitchison & Chad A. Bousman. (2020) Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada. The Canadian Journal of Psychiatry 65:8, pages 521-530.
Crossref
Crossref
Stuart Banham & David Taylor. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
124
150
.
Jonathan C.W. Liu, Ilona Gorbovskaya, Chad Bousman, Lisa C. Brown & Daniel J. Müller. 2020. Personalized Psychiatry. Personalized Psychiatry
449
457
.
Chad A. Bousman, Lisa C. Brown, Ajeet B. Singh, Harris A. Eyre & Daniel J. Müller. 2020. Personalized Psychiatry. Personalized Psychiatry
437
448
.
Reinier L. Sluiter, Joost G. E. Janzing, Gert Jan van der Wilt, Wietske Kievit & Martina Teichert. (2019) An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care. The Pharmacogenomics Journal 19:5, pages 480-489.
Crossref
Crossref
Lucas M. Walden, Eva J. Brandl, Arun K. Tiwari, Sheraz Cheema, Natalie Freeman, Nicole Braganza, James L. Kennedy & Daniel J. Müller. (2019) Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication. Psychiatry Research 279, pages 111-115.
Crossref
Crossref
Maria J. Arranz, Alex Gonzalez-Rodriguez, Josefina Perez-Blanco, Rafael Penadés, Blanca Gutierrez, Laura Ibañez, Barbara Arias, Mercè Brunet, Jorge Cervilla, Juliana Salazar & Rosa Catalan. (2019) A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments. Translational Psychiatry 9:1.
Crossref
Crossref
L. K. Khokhlov & N. E. Lukyanov. (2019) Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:2, pages 33-43.
Crossref
Crossref
Xenia Gonda, Peter Petschner, Nora Eszlari, Daniel Baksa, Andrea Edes, Peter Antal, Gabriella Juhasz & Gyorgy Bagdy. (2019) Genetic variants in major depressive disorder: From pathophysiology to therapy. Pharmacology & Therapeutics 194, pages 22-43.
Crossref
Crossref
Haley V. Solomon, Kevin W. Cates & Kevin J. Li. (2019) Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?. Psychiatry Research 271, pages 604-613.
Crossref
Crossref
Y. W. Francis Lam. 2019. Pharmacogenomics. Pharmacogenomics
385
394
.
Y. W. Francis Lam & Toshiyuki Someya. 2019. Pharmacogenomics. Pharmacogenomics
181
225
.
Anne B. Koopmans, David J. Vinkers, Igmar T. Poulina, Petra J. A. Gelan, Ron H. N. van Schaik, Hans W. Hoek & Peter N. van Harten. (2018) No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness. Frontiers in Psychiatry 9.
Crossref
Crossref
D. J. Müller, E. J. Brandl, F. Degenhardt, K. Domschke, H. Grabe, O. Gruber, J. Hebebrand, W. Maier, A. Menke, M. Riemenschneider, M. Rietschel, D. Rujescu, T. G. Schulze, L. Tebartz van Elst, O. Tüscher & J. Deckert. (2018) Pharmakogenetik in der Psychiatrie: eine StandortbestimmungPharmacogenetics in psychiatry: state of the art. Der Nervenarzt 89:3, pages 290-299.
Crossref
Crossref
Deanna Herbert, Maria Neves-Pereira, Ruth Baidya, Sheraz Cheema, Sarah Groleau, Anashe Shahmirian, Arun K. Tiwari, Clement C. Zai, Nicole King, Daniel J. Müller & James L. Kennedy. (2018) Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study. Journal of Psychiatric Research 96, pages 265-272.
Crossref
Crossref
Chiara Fabbri & Alessandro Serretti. 2018. Understanding Depression. Understanding Depression
3
16
.
Meryem Ozlem Kutuk, Gulen Guler, Ali Evren Tufan & Ozgur Kutuk. (2017) Hiccup Due to Aripiprazole Plus Methylphenidate Treatment in an Adolescent with Attention Deficit and Hyperactivity Disorder and Conduct Disorder: A Case Report. Clinical Psychopharmacology and Neuroscience 15:4, pages 410-412.
Crossref
Crossref
S Harada, Y Zhou, S Duncan, AR Armstead, GM Coshatt, C Dillon, BC Brott, J Willig, JA Alsip, WB Hillegass & NA Limdi. (2017) Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype‐Guided Antiplatelet Therapy. Clinical Pharmacology & Therapeutics 102:3, pages 493-501.
Crossref
Crossref
Thi Minh Tam Ta, Eric Hahn, Isabella Heuser & Julian Hellmann-Regen. (2017) „Poor metabolizer“ im interkulturellen Setting. NeuroTransmitter 28:7-8, pages 44-48.
Crossref
Crossref
Kimberly Peterson, Eric Dieperink, Johanna Anderson, Erin Boundy, Lauren Ferguson & Mark Helfand. (2017) Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder. Psychopharmacology 234:11, pages 1649-1661.
Crossref
Crossref
Chad A. Bousman, Daniel J. Müller, Chee H. Ng, Keith Byron, Michael Berk & Ajeet B. Singh. (2017) Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder. Pharmacogenetics and Genomics 27:1, pages 1-6.
Crossref
Crossref
Tristram A. Lett, Henrik Walter & Eva J. Brandl. (2016) Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. CNS Drugs 30:12, pages 1169-1189.
Crossref
Crossref
Rachel K Lanning, Clement C Zai & Daniel J Müller. (2016) Pharmacogenetics of tardive dyskinesia: an updated review of the literature. Pharmacogenomics 17:12, pages 1339-1351.
Crossref
Crossref
J. Kevin Hicks, David Stowe, Marc A. Willner, Maya Wai, Thomas Daly, Steven M. Gordon, Bret A. Lashner, Sumit Parikh, Robert White, Kathryn Teng, Timothy Moss, Angelika Erwin, Jeffrey Chalmers, Charis Eng & Scott Knoer. (2016) Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:8, pages 940-948.
Crossref
Crossref
LV Kalman, JAG Agúndez, M Lindqvist Appell, JL Black, GC Bell, S Boukouvala, C Bruckner, E Bruford, K Caudle, SA Coulthard, AK Daly, AL Del Tredici, JT den Dunnen, K Drozda, RE Everts, D Flockhart, RR Freimuth, A Gaedigk, H Hachad, T Hartshorne, M Ingelman-Sundberg, TE Klein, VM Lauschke, DR Maglott, HL McLeod, GA McMillin, UA Meyer, DJ Müller, DA Nickerson, WS Oetting, M Pacanowski, VM Pratt, MV Relling, A Roberts, WS Rubinstein, K Sangkuhl, M Schwab, SA Scott, SC Sim, RK Thirumaran, LH Toji, RF Tyndale, RHN van Schaik, M Whirl-Carrillo, KTJ Yeo & UM Zanger. (2016) Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting. Clinical Pharmacology & Therapeutics 99:2, pages 172-185.
Crossref
Crossref
Greyson P Twist, Andrea Gaedigk, Neil A Miller, Emily G Farrow, Laurel K Willig, Darrell L Dinwiddie, Josh E Petrikin, Sarah E Soden, Suzanne Herd, Margaret Gibson, Julie A Cakici, Amanda K Riffel, J Steven Leeder, Deendayal Dinakarpandian & Stephen F Kingsmore. (2016) Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences. npj Genomic Medicine 1:1.
Crossref
Crossref
Raymond R. MacNeil & Daniel J. Müller. (2016) Genetics of Common Antipsychotic-Induced Adverse Effects. Complex Psychiatry 2:2, pages 61-78.
Crossref
Crossref
Malgorzata Maciukiewicz, Venuja Sriretnakumar & Daniel J. Müller. 2016. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
21
38
.
Andrea Gaedigk, Amanda K. Riffel & J. Steven Leeder. (2015) CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification. The Journal of Molecular Diagnostics 17:6, pages 740-748.
Crossref
Crossref
Lucas M. Walden, Eva J. Brandl, Amtul Changasi, Jessica E. Sturgess, Alexander Soibel, Janna Fe D. Notario, Sheraz Cheema, Nicole Braganza, Victoria S. Marshe, Natalie Freeman, Arun K. Tiwari, James L. Kennedy & Daniel J. Müller. (2015) Physicians' opinions following pharmacogenetic testing for psychotropic medication. Psychiatry Research 229:3, pages 913-918.
Crossref
Crossref
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, A LLerena, TC Skaar, SA Scott, JC Stingl, TE Klein, KE Caudle & A Gaedigk. (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for
CYP2D6
and
CYP2C19
Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
. Clinical Pharmacology & Therapeutics 98:2, pages 127-134.
Crossref
Crossref
Chiara Fabbri & Alessandro Serretti. (2015) Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications. Current Psychiatry Reports 17:7.
Crossref
Crossref
Gudrun Hefner, Anne Brueckner, Christoph Hiemke & Andreas Fellgiebel. (2015) Therapeutic Drug Monitoring for Patients With Alzheimer Dementia to Improve Treatment With Donepezil. Therapeutic Drug Monitoring 37:3, pages 353-361.
Crossref
Crossref
Andrea Gaedigk, Natalie Freeman, Toinette Hartshorne, Amanda K. Riffel, David Irwin, Jeffrey R. Bishop, Mark A. Stein, Jeffrey H. Newcorn, Lazara Karelia Montané Jaime, Mariana Cherner & J. Steven Leeder. (2015) SNP genotyping using TaqMan® technology: the CYP2D6*17 assay conundrum. Scientific Reports 5:1.
Crossref
Crossref
Carmela Thompson, Steven P. Hamilton & Catriona Hippman. (2015) Psychiatrist attitudes towards pharmacogenetic testing, direct-to-consumer genetic testing, and integrating genetic counseling into psychiatric patient care. Psychiatry Research 226:1, pages 68-72.
Crossref
Crossref
Katharina Domschke, Daniel J. Müller & Alessandro Serretti. (2014) Personalized therapies in psychiatry: promises, pitfalls and perspectives. Journal of Neural Transmission 122:1, pages 1-3.
Crossref
Crossref
Eva J. Brandl, Nabilah I. Chowdhury, Arun K. Tiwari, Tristram A. P. Lett, Herbert Y. Meltzer, James L. Kennedy & Daniel J. Müller. (2014) Genetic variation in CYP3A43 is associated with response to antipsychotic medication. Journal of Neural Transmission 122:1, pages 29-34.
Crossref
Crossref
Andreas Heinz, Daniel J. Müller, Sören Krach, Maurice Cabanis & Ulrike P. Kluge. (2014) The uncanny return of the race concept. Frontiers in Human Neuroscience 8.
Crossref
Crossref
Eva J Brandl, James L Kennedy & Daniel J Müller. (2014) Pharmacogenetics of Antipsychotics. The Canadian Journal of Psychiatry 59:2, pages 76-88.
Crossref
Crossref